Načítá se...
Safety, compliance, and predictive parameters for dosage modification in adjuvant S‐1 chemotherapy for gastric cancer
This study was performed to investigate the compliance, safety, dosage modifications (dose reduction and/or schedule change [including permanent S‐1 withdrawal]), and clinical parameters that predict S‐1 dosage modification in gastric cancer patients receiving adjuvant S‐1 chemotherapy. One hundred...
Uloženo v:
| Vydáno v: | Cancer Sci |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657188/ https://ncbi.nlm.nih.gov/pubmed/23066919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12044 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|